ABVC vs HCAT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

ABVC

36.4
AI Score
VS
HCAT Wins

HCAT

44.4
AI Score

Investment Advisor Scores

ABVC

36score
Recommendation
AVOID NEW MONEY

HCAT

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABVC HCAT Winner
Forward P/E 0 10 Tie
PEG Ratio 0 0 Tie
Revenue Growth 104.5% -12.7% ABVC
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 36.4/100 44.4/100 HCAT
Profit Margin 0.0% -90.6% ABVC
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD HCAT

Relative Price Performance (Last 90 Days)

ABVC 1M: +23.6% · 3M: -43.3% HCAT 1M: -0.6% · 3M: -18.3%

Current Technical Phase

ABVC

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -14.9%) with fading momentum, RSI 48

RSI (14): 48.0 · Price: $1.02

HCAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.4 · Price: $1.70

Fundamentals Snapshot

Metric ABVC HCAT
Market Cap — —
Forward P/E 0.0 226.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 1.0% -0.1%
Gross Margin 1.0% 0.5%
Operating Margin 0.0% -0.1%
EPS -0.29 -3.73
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HCAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.